Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)

Completed · Phase 3 · Has a placebo group

Conditions studied: Atopic Dermatitis

In brief

This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in the United States in subjects with atopic dermatitis.

Key facts

Study ID
NCT03568331
Run by
Vanda Pharmaceuticals
People needed
375
Starts
2018-07-09
Expected to finish
2019-12-27
Last updated by the study team
2024-05-13

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.